PUFA polyketide synthase systems and uses thereof
View Patent ↗Disclosed are the complete polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems from Schizochytrium , and biologically active fragments and homologues thereof. More particularly, this invention relates to nucleic acids encoding such PUFA PKS systems, to proteins and domains thereof that comprise such PUFA PKS systems, to genetically modified organisms (plants and microorganisms) comprising such PUFA PKS systems, and to methods of making and using the PUFA PKS systems disclosed herein. This invention also relates to genetically modified plants and microorganisms and methods to efficiently produce lipids enriched in various polyunsaturated fatty acids (PUFAs) as well as other bioactive molecules by manipulation of a PUFA polyketide synthase (PKS) system.
1. An isolated nucleic acid molecule comprising a nucleic acid sequence comprising a first nucleic acid sequence encoding a first amino acid sequence that has β-keto acyl-ACP synthase (KS) activity, malonyl-CoA:ACP acyltransferase (MAT) activity, acyl carrier protein (ACP) activity and ketoreductase (KR) activity, wherein the first nucleic acid sequence hybridizes under moderate, high, or very high stringency conditions to the complement of a second nucleic acid sequence encoding a second amino acid sequence of SEQ ID NO:2, and wherein said first amino acid sequence comprises an aspartate at a position corresponding to amino acid 667 of SEQ ID NO:2 and a histidine at a position corresponding to amino acid 668 of SEQ ID NO:2.
2. The isolated nucleic acid molecule of claim 1 , wherein the first nucleic acid sequence is isolated from a Schizochytrium.
3. The isolated nucleic acid molecule of claim 1 , wherein the first nucleic acid sequence is isolated from Schizochytrium deposited as ATCC Accession No. 20888.
4. A recombinant nucleic acid molecule comprising the nucleic acid molecule of claim 1 operatively linked to at least one transcription control sequence.
5. A recombinant cell transfected with the nucleic acid molecule of claim 1 .
6. An isolated nucleic acid molecule consisting of a nucleic acid sequence that is fully complementary to the nucleic acid molecule of claim 1 .
7. A genetically modified microorganism that has been transformed with the nucleic acid molecule of claim 1 .
8. A genetically modified plant that has been transformed with the nucleic acid molecule of claim 1 .
9. The isolated nucleic acid molecule of claim 1 , wherein said nucleic acid molecule when expressed in a host cell, modulates the production of a long chain polyunsaturated fatty acid.
10. The isolated nucleic acid molecule of claim 9 , wherein said long chain polyunsaturated fatty acid is docosahexaenoic acid.
11. The isolated nucleic acid molecule of claim 9 , wherein said long chain polyunsaturated fatty acid is docosapentaenoic acid DPA.
12. The isolated nucleic acid molecule of claim 9 , wherein said long chain polyunsaturated fatty acid is eicosapentaenoic acid.
13. The isolated nucleic acid molecule of claim 9 , wherein the host cell is a bacterium.
14. The isolated nucleic acid molecule of claim 9 , wherein the host cell is a yeast cell.
15. The isolated nucleic acid molecule of claim 9 , wherein the host cell is a plant cell.
16. The isolated nucleic acid molecule of claim 1 , wherein the first nucleic acid sequence hybridizes under moderate stringency conditions to the complement of the second nucleic acid sequence.
17. The isolated nucleic acid molecule of claim 1 , wherein the first nucleic acid sequence hybridizes under high stringency conditions to the complement of the second nucleic acid sequence.
18. The isolated nucleic acid molecule of claim 1 , wherein the first nucleic acid sequence hybridizes under very high stringency conditions to the complement of the second nucleic acid sequence.